Quality of ChatGPT-Generated Therapy Recommendations for Breast Cancer Treatment in Gynecology

Autor: Jan Lennart Stalp, Agnieszka Denecke, Matthias Jentschke, Peter Hillemanns, Rüdiger Klapdor

Publikováno v: Current Oncology, Vol 31, Iss 7, Pp 3845-3854 (2024)

Introduction: Artificial intelligence (AI) is revolutionizing medical workflows, with self-learning systems like ChatGPT showing promise in therapy recommendations. Our study evaluated ChatGPT’s performance in suggesting treatments for 30 breast ca

Externí odkaz: https://doaj.org/article/e136c6fbc9d84f948d5d3b5fd2a522a4

Association of two genomic variants with HPV type-specific risk of cervical cancer

Autor: Finja Seifert, Rieke Eisenblätter, Julia Beckmann, Peter Schürmann, Patricia Hanel, Matthias Jentschke, Gerd Böhmer, Hans-Georg Strauß, Christine Hirchenhain, Monika Schmidmayr, Florian Müller, Peter Fasching, Alexander Luyten, Norman Häfner, Matthias Dürst, Ingo B. Runnebaum, Peter Hillemanns, Thilo Dörk, Dhanya Ramachandran

Publikováno v: Tumour Virus Research, Vol 16, Iss , Pp 200269- (2023)

Problem: Human papillomavirus infection is integral to developing invasive cervical cancer in the majority of patients. In a recent genome-wide association study, rs9357152 and rs4243652 have been associated with seropositivity for HPV16 or HPV18, re

Externí odkaz: https://doaj.org/article/eb5f067695d1403fb0c1ad541df1697b

Evaluation of FAM19A4/miR124-2 methylation performance in the management of CIN3 diagnosed pregnant women

Autor: Monika, Hampl, Albertus T, Hesselink, Chris J L M, Meijer, Agnieszka, Denecke, Ina, Einhorn, Axel, Reinecke-Luethge, Carol I, Geppert, Matthias, Jentschke, Karl U, Petry, Peter, Hillemanns

Publikováno v: International Journal of Cancer, 151(9), 1578-1585. Wiley-Liss Inc.
Members of the German Study Group of Colposcopy (SGK) 2022, ' Evaluation of FAM19A4/miR124-2 methylation performance in the management of CIN3 diagnosed pregnant women ', International Journal of Cancer, vol. 151, no. 9, pp. 1578-1585 . https://doi.org/10.1002/ijc.34153

Pregnant women diagnosed with CIN3 have high regression rates after delivery. Biomarkers are needed to only identify pregnant women with progressive CIN requiring treatment to reduce overreferral and overtreatment. In our study we evaluated the perfo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17c6572a4268a282e47c20640bf6d502
http://www.scopus.com/inward/record.url?scp=85133649282&partnerID=8YFLogxK

Supplementary Data from A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial

Autor: Agnete B. Fredriksen, Karsten M.H. Bruins Slot, Karoline W. Schjetne, Matthias Jentschke, Gerd Böhmer, Linn Woelber, Agnieszka Denecke, Peter Hillemanns

Supplementary Data from A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a42f3ff036cc9a0d25a854da0517577
https://doi.org/10.1158/1078-0432.22488869.v1

Data from A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial

Autor: Agnete B. Fredriksen, Karsten M.H. Bruins Slot, Karoline W. Schjetne, Matthias Jentschke, Gerd Böhmer, Linn Woelber, Agnieszka Denecke, Peter Hillemanns

Purpose:To evaluate the safety, immunogenicity and efficacy of a therapeutic DNA vaccine VB10.16, using a unique modular vaccine technology that is based on linking antigens to CCL3L1 targeting module, in women with HPV16-positive high-grade cervical

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30fe19c6dd8e20bd98cea1f4fd0934ce
https://doi.org/10.1158/1078-0432.c.6532823.v1